Research AboutOfferDocumentationLoginBook a demo
ResearchAboutOfferLoginBook a demo

InnoCore Pharmaceuticals

Ownership
Private
Therapeutic Areas
OncologyOphthalmologyNeurologyWomen's Health
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculePeptidesProtein therapeuticsPolymer-drug conjugate therapy (via depot/controlled release systems)Nanoparticle (as a delivery system)Microsphere-based drug delivery systemImplant-based drug delivery systemGel-based drug delivery system

InnoCore Pharmaceuticals General Information

InnoCore does not have its own therapeutic pipeline but has supported over twenty product development projects using its proprietary controlled-release technologies. The company’s SynBiosys® platform enables long-term injectable formulations for small molecules and biologics. It has been recognized by major partners such as Allergan in ophthalmology and MilliporeSigma globally. Clinical results pertain to partner/client products utilizing their platforms rather than internal assets.

Contact Information

Website
https://www.innocorepharma.com/nl/Media/News/Merck-and-InnoCore-Pharmaceuticals-to-Improve-Patient-Compliance-with-New-Drug-Delivery-Technology
Primary Industry
Drug Discovery Services
Corporate Office
Groningen,
Netherlands

Drug Pipeline

No pipeline data available

For full access to InnoCore Pharmaceuticals's pipeline data

Book a demo

Key Partnerships

Allergan (exclusive license in ophthalmology), MilliporeSigma/Merck KGaA (global cooperation on SynBiosys® platform), Orbus Neich (CE Marked product using SynBiosys®), Surmodics Inc. (device coatings license), Bill & Melinda Gates Foundation-supported contraceptive implant project consortium

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

InnoCore Pharmaceuticals Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view InnoCore Pharmaceuticals's complete valuation and funding history, request access »

InnoCore Pharmaceuticals Financial Metrics

See full profile
Book a demo
OverviewDrug PipelineTechnologiesPartnershipsFundingCompetitorsAnalysisPatentsLicensing Deals